Bonk (NASDAQ:BNKK) Stock Rating Upgraded by Wall Street Zen

Bonk (NASDAQ:BNKK) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued on Saturday.

Separately, Weiss Ratings lowered shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, April 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.

Bonk Stock Performance

NASDAQ:BNKK opened at $1.45 on Friday. The stock has a 50-day simple moving average of $1.90 and a 200-day simple moving average of $2.82. The stock has a market cap of $11.60 million, a P/E ratio of -0.31 and a beta of 1.89. Bonk has a 1 year low of $1.25 and a 1 year high of $46.90.

Bonk (NASDAQ:BNKK) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.23) EPS for the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%. The business had revenue of $0.79 million during the quarter.

Insiders Place Their Bets

In related news, Director Mitchell Austin Rudy acquired 31,055 shares of the firm’s stock in a transaction on Thursday, April 9th. The stock was bought at an average price of $2.82 per share, for a total transaction of $87,575.10. Following the completion of the purchase, the director directly owned 44,198 shares of the company’s stock, valued at approximately $124,638.36. The trade was a 236.29% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders have acquired 53,055 shares of company stock valued at $119,015 over the last three months. 51.60% of the stock is owned by insiders.

Institutional Trading of Bonk

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. State Street Corp acquired a new stake in shares of Bonk during the fourth quarter worth about $33,000. Steward Partners Investment Advisory LLC acquired a new stake in shares of Bonk in the 4th quarter valued at about $37,000. Jane Street Group LLC acquired a new stake in shares of Bonk in the 4th quarter valued at about $96,000. Finally, Geode Capital Management LLC purchased a new position in Bonk during the 4th quarter worth approximately $128,000. Institutional investors and hedge funds own 12.55% of the company’s stock.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.